Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP353588.RA6P_cPC_D6CNfqwepH9GZ3Eo6M7noM9jKDnKpxbcUMa0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP353588.RA6P_cPC_D6CNfqwepH9GZ3Eo6M7noM9jKDnKpxbcUMa0130_assertion type Assertion NP353588.RA6P_cPC_D6CNfqwepH9GZ3Eo6M7noM9jKDnKpxbcUMa0130_head.
- NP353588.RA6P_cPC_D6CNfqwepH9GZ3Eo6M7noM9jKDnKpxbcUMa0130_assertion description "[beta-Lapachone killed cells in a tumorselective manner and is indicated for use against NQO1+ NSCLC cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP353588.RA6P_cPC_D6CNfqwepH9GZ3Eo6M7noM9jKDnKpxbcUMa0130_provenance.
- NP353588.RA6P_cPC_D6CNfqwepH9GZ3Eo6M7noM9jKDnKpxbcUMa0130_assertion evidence source_evidence_literature NP353588.RA6P_cPC_D6CNfqwepH9GZ3Eo6M7noM9jKDnKpxbcUMa0130_provenance.
- NP353588.RA6P_cPC_D6CNfqwepH9GZ3Eo6M7noM9jKDnKpxbcUMa0130_assertion SIO_000772 17609380 NP353588.RA6P_cPC_D6CNfqwepH9GZ3Eo6M7noM9jKDnKpxbcUMa0130_provenance.
- NP353588.RA6P_cPC_D6CNfqwepH9GZ3Eo6M7noM9jKDnKpxbcUMa0130_assertion wasDerivedFrom befree-20140225 NP353588.RA6P_cPC_D6CNfqwepH9GZ3Eo6M7noM9jKDnKpxbcUMa0130_provenance.
- NP353588.RA6P_cPC_D6CNfqwepH9GZ3Eo6M7noM9jKDnKpxbcUMa0130_assertion wasGeneratedBy ECO_0000203 NP353588.RA6P_cPC_D6CNfqwepH9GZ3Eo6M7noM9jKDnKpxbcUMa0130_provenance.